Written Question · S4W-02716 · Session 4
What the impact of global price pressures on generic drugs has been on the NHS’s prescribing bill in the last three years.
The question
To ask the Scottish Executive what the impact of global price pressures on generic drugs has been on the NHS’s prescribing bill in the last three years.
The answer
Prescription drugs dispensed in the community are purchased by community pharmacists, who are then reimbursed.
Reimbursement arrangements for community pharmacists for all drugs, including generics, are subject to regular review to encourage them to seek out prices which deliver value for money to NHS Scotland. The prices they pay for generic drugs change monthly and vary from product to product and with market conditions.
The reimbursement arrangements for proprietary (branded) drugs are subject to the provisions of the Pharmaceutical Price Regulation Scheme which applies across the United Kingdom. This was updated in 2009 and is delivering recurring savings to NHS Scotland.
The Scottish Government’s Efficiency Programme over the period 2009-10 to
2010-11 has included savings in the costs of drugs dispensed by the NHS in Scotland. The total savings achieved in respect of each of the programme in respect of drugs purchasing are published at:
http://www.scotland.gov.uk/Publications/2009/11/Outturn2008-09
http://www.scotland.gov.uk/Publications/2010/10/Outturn2009-10
http://www.scotland.gov.uk/Publications/2011/09/Outturn2010-11.
Year on year prescribing costs for all NHS boards including generic drugs are published by the Information and Statistics Division of NHS National Services Scotland at:
http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Community-Dispensing/Prescription-Cost-Analysis/.
Reimbursement arrangements for community pharmacists for all drugs, including generics, are subject to regular review to encourage them to seek out prices which deliver value for money to NHS Scotland. The prices they pay for generic drugs change monthly and vary from product to product and with market conditions.
The reimbursement arrangements for proprietary (branded) drugs are subject to the provisions of the Pharmaceutical Price Regulation Scheme which applies across the United Kingdom. This was updated in 2009 and is delivering recurring savings to NHS Scotland.
The Scottish Government’s Efficiency Programme over the period 2009-10 to
2010-11 has included savings in the costs of drugs dispensed by the NHS in Scotland. The total savings achieved in respect of each of the programme in respect of drugs purchasing are published at:
http://www.scotland.gov.uk/Publications/2009/11/Outturn2008-09
http://www.scotland.gov.uk/Publications/2010/10/Outturn2009-10
http://www.scotland.gov.uk/Publications/2011/09/Outturn2010-11.
Year on year prescribing costs for all NHS boards including generic drugs are published by the Information and Statistics Division of NHS National Services Scotland at:
http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Community-Dispensing/Prescription-Cost-Analysis/.
In the Official Report
No contribution in the Official Report cites S4W-02716 by reference.